4DMedical Limited (FDMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.2279
-0.1121 (-32.97%)
At close: Apr 16, 2025
4DMedical Revenue
4DMedical had revenue of 2.90M AUD in the half year ending December 31, 2024, with 495.89% growth. This brings the company's revenue in the last twelve months to 5.86M, up 471.29% year-over-year. In the fiscal year ending June 30, 2024, 4DMedical had annual revenue of 3.75M with 422.45% growth.
Revenue (ttm)
5.86M AUD
Revenue Growth
+471.29%
P/S Ratio
23.62
Revenue / Employee
40.39K AUD
Employees
145
Market Cap
85.63M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.75M | 3.04M | 422.45% |
Jun 30, 2023 | 718.58K | -335.72K | -31.84% |
Jun 30, 2022 | 1.05M | 837.32K | 385.90% |
Jun 30, 2021 | 216.98K | -1.02M | -82.40% |
Jun 30, 2020 | 1.23M | 537.50K | 77.34% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |